Hello! I'm your financial analyst friend. Today, let's talk about the company ST Bai Ling (002424.SZ) and its controversial controlling shareholder, Jiang Wei, who is both loved and hated by investors.
At first glance, this news seems full of legal jargon and numbers, but the core story is quite clear: The owner of the company has been punished twice in less than half a year for reasons related to financial fraud and illegal stock trading activities, with the total fines amounting to over 300 million yuan.
It's like someone who was just released from prison after a six-month sentence for theft and is then arrested again for fraud. For the company and its shareholders, this is a devastating blow.
I'll break down the news into five key points to explain it in simpler terms:
1. The Owner's Second Incarceration: Two Punishments in Half a Year, This Time Even More Severe
First, let's understand what exactly Jiang Wei did and why the punishments are so severe:
- Background (March): In March this year, Jiang Wei was fined 5 million yuan and banned from the securities market for 10 years for four years of financial fraud, which involved manipulating financial records to inflate profits.
- New Case (September): On September 9, the Securities Regulatory Commission issued another penalty against him, accusing him of insider trading, failing to disclose his stock holdings accurately, and illegally trading stocks.
- Punishment: The proposed penalty is a fine and confiscation of 311 million yuan, and he will be banned from the securities market for another five years.
In simple terms: Jiang Wei has a history of financial fraud and has now added insider trading to his record. Insider trading is a serious offense in securities law because it undermines market fairness—some people profit from inside information, while ordinary investors rely on luck or analysis. The 300 million yuan fine is a huge amount for an individual, showing the authorities' strict stance against such violations.
2. How Did Jiang Wei Commit Insider Trading?
Many may wonder how, as the chairman, he could still engage in insider trading. The news reveals some sophisticated but also secretive methods:
- How He “Hidden” His Identity: Jiang Wei didn't use his own account to trade. Instead, he used private equity funds to hold the stocks or used complex over-the-counter derivatives to indirectly control them. This made it seem like the stocks weren't in his name, but he still had control over their transactions.
- How He Obtained Inside Information: He learned two crucial pieces of confidential information:
1. The company was going to suffer a significant loss, which became known before March 19, 2024, but was only made public on April 30.
2. There were major issues with the company's accounting, which became known before March 28, 2024, but was also not disclosed until April 30.
- **How He “Hedged”: In the half-month before the information was made public (April 15–29), he instructed the private equity funds to sell the stocks and terminated the derivatives contracts. As a result, he avoided losses of 156 million yuan. This is a typical example of using insider information to profit before bad news became public.
In simple terms: It's like knowing your house is about to catch fire tomorrow, so you move valuable items out tonight or buy insurance to shift the risk to others, then act as if nothing happened the next day. Jiang Wei used financial tools to transfer the risk to others and protect his own assets.
3. More Than Just Stock Trading: Misleading Information and Illegal Sales
Besides insider trading, Jiang Wei committed two other violations:
- Misleading Information: From March 2022 to April 2024, he held ST Bai Ling stocks through multiple accounts without informing the company, leading to false information in the company's public disclosures. This misled investors.
- Illegal Stock Sales: Between October 2022 and January 2023, he sold restricted stocks through specific accounts, violating regulations on the timing of such sales.
In simple terms: Misleading information is like hiding money, and illegal sales are like misappropriating company funds. These actions show a complete disregard for regulatory rules, treating the company as a personal wealth source.
4. The Company's Poor Performance and Weak Internal Controls
What about the company itself? The situation is dire:
- History of Financial Fraud: ST Bai Ling underfunded its expenses for three consecutive years (2019–2021), inflating profits artificially.
- 2019: Overstated profits by 350 million yuan (more than 95% of total profits).
- 2020: Overstated profits by 241 million yuan.
- 2021: Overstated profits by 63.79 million yuan.
- 2023: Understated expenses by 459 million yuan.
- Continuing Decline in Performance: In 2025, revenue was 3.049 billion yuan, a 20% decrease; net profit was a loss of 104 million yuan, a 410% decrease. In the first half of 2026, revenue was 970 million yuan, a 33% decrease, and net profit was 30.02 million yuan, a 42% decrease.
- Industry Challenges: The company operates in the pharmaceutical sector, which is facing pressure from government policies that lower drug prices and reduce hospital spending.
In simple terms: The company's financial records are unreliable, and its internal controls are ineffective. The poor performance reflects serious management issues.
5. The Company's Future: Uncertain Control and Rebuilding Trust
What lies ahead for ST Bai Ling? Investors are concerned about whether the company can be saved:
- The Absent Controlling Shareholder: Although Jiang Wei no longer holds the chairman position, he remains the actual controller. Another person is unable to take on responsibilities due to legal issues, creating a governance vacuum.
- Debt Troubles: Jiang Wei has a debt dispute of over 1.7 billion yuan with Huachuang Securities, the company's second-largest shareholder. If he's ordered to pay, his stocks could be seized, potentially changing control of the company. Who will become the new owner and how will they manage the company?
- No Hope of Removal of the “ST” Label: The “ST” designation is due to financial fraud and poor internal controls. Reversing this requires significant reforms, improved performance, and completion of legal penalties. Given Jiang Wei's repeated violations and the company's poor performance, this is unlikely in the short term.
- Investor Claims: Investors affected by financial fraud and insider trading are suing for compensation, adding financial pressure and legal risks.
In simple terms: ST Bai Ling is in a difficult situation: its management is unreliable, its performance is declining, and it faces legal and financial pressures.
Summary and Advice:
For ordinary investors, ST Bai Ling is a high-risk, low-reward investment. The company has a poor financial record, weak governance, and significant risks. Unless there is significant external intervention (such as state-owned investment or a new, responsible owner), it's unlikely to recover soon. For those considering buying shares at low prices, this is a risky move. It's best to stay away and wait for clearer signs of improvement in the company's governance.